Keck School Faculty

Frances Chow

Frances Chow

Assistant Professor of Clinical Neurological Surgery and Neurology
Surgery
2204 Alcazar Street Health Sciences Campus Los Angeles

Contact

Super Doctors: Rising Stars Award, 2022

Pasadena Magazine: Top Doctor Award, 2022

Los Angeles Magazine: LA's Top Doctors Award, 2022

Pasadena Magazine: Pasadena's Top Doctors Award, 2022

Los Angeles Magazine: Top Doctor Award, 2022

Super Doctors: Rising Stars Award, 2021

Super Doctors: Rising Stars Award, 2020

Keck School of Medicine of USC: Outstanding Teaching Award, 2018

MR multitasking-based dynamic imaging for cerebrovascular evaluation (MT-DICE): Simultaneous quantification of permeability and leakage-insensitive perfusion by dynamic T1/T2* mapping Magn Reson Med. 2022 Sep 21. . View in PubMed

The Abscopal Effect: Systematic Review in Patients with Brain and Spine Metastases Neurooncol Adv. 2022. . View in PubMed

Anaplastic Pleomorphic Xanthoastrocytoma with Extracranial Bone Metastasis: A Case Report and Literature Review Neurology. 2022; 18(98):1251. . View in PubMed

Two Rare Cases of Glioma in Total Spine with Metastases to Brain Neurology. 2022; 18(98):3885. . View in PubMed

Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac119. . View in PubMed

Interplay between B cell and GABA metabolism (GABAm) and association with immune evasion in breast carcinoma (BC) Journal of Clinical Oncology. 2022; 16(40):1097. . View in PubMed

Utilization of Discarded Surgical Tissue from Ultrasonic Aspirators to Establish Patient-Derived Metastatic Brain Tumor Cells: A Guide from the Operating Room to the Research Laboratory Curr Protoc. 2021 Jun; 1(6):e140. . View in PubMed

Comorbid depression in surgical cancer patients associated with non-routine discharge and readmission Surg Oncol. 2021 Jun; 37:101533. . View in PubMed

Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles World Neurosurg. 2021 07; 151:e682-e692. . View in PubMed

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab005. . View in PubMed

Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 Nat Commun. 2021 06 29; 12(1):4031. . View in PubMed

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma Nat Commun. 2021 11 26; 12(1):6938. . View in PubMed

Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunologyMeeting Report from the 2019 SNO Immuno-Oncology Think Tank. Neuro Oncol. 2021 03 25; 23(3):356-375. . View in PubMed

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma (in press) Nature Commun. 2021. . View in PubMed

A phase 1 with dose expansion/phase 2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma Neuro-Oncology. 2021; 6(23):vi62-63. . View in PubMed

Validation of response to neoadjuvant anti-PD-1 immunotherapy in recurrent glioblastoma Neuro-Oncology. 2020; 21(6):vi4-vi5. . View in PubMed

Neoadjuvant PD-1 antibody blockade remodels the immune microenvironment of metastatic brain tumors Neuro-Oncology. 2020; 2(22):ii212-ii213. . View in PubMed

Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa009. . View in PubMed

Single-cell RNAseq of tumor infiltrating immune cells from neoadjuvant anti-PD1 treated GBM patients reveals global transcriptional changes and immunosuppressive adaptive responses by myeloid cells Neuro-Oncology. 2020; 2(22):ii108-ii109. . View in PubMed

Neoantigens arising from alternative splicing events may be targeted by tumor infiltrating lymphocytes in glioblastomas Neuro-Oncology. 2019; 21(6):vi118-vi119. . View in PubMed

Neuro-Oncology Myeloid populations and the effect of neoadjuvant PD-1 inhibition in the glioblastoma microenvironment: a surfaceomic and transcriptomic dissection at the single-cell level. 2019; 21(6):vi248. . View in PubMed

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease Front Neurol. 2019; 10:1140. . View in PubMed

Myeloid populations and the effect of neoadjuvant PD-1 inhibition in the glioblastoma microenvironment: a surfaceomic and transcriptomic dissection at the single-cell level Neuro-Oncology. 2019; 21(6):vi248. . View in PubMed

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series CNS Oncol. 2019 06 01; 8(2):CNS35. . View in PubMed

Treatment at Safety-Net Hospitals Is Associated with Delays in Coil Embolization in Patients with Subarachnoid Hemorrhage World Neurosurg. 2018 Dec; 120:e434-e439. . View in PubMed

The challenge of distinguishing POEMS from chronic inflammatory demyelinating polyneuropathy US Neurology. 2018; 2(14):94-7. . View in PubMed

Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease Neural Plast. 2017; 2017:3270725. . View in PubMed

The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition Am J Alzheimers Dis Other Demen. 2014 Jun; 29(4):303-10. . View in PubMed

Molecular characteristics and pathways of Avastin for the treatment of glioblastoma multiforme Neurosurg Clin N Am. 2012 Jul; 23(3):417-27. . View in PubMed

Temozolomide and other potential agents for the treatment of glioblastoma multiforme Neurosurg Clin N Am. 2012 Apr; 23(2):307-22ix. . View in PubMed

sc ctsi logoPowered by SC CTSI